Displaying drugs 1826 - 1850 of 2779 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Olaparib | 434.4628 C24H23FN4O3 |  | A poly (ADP-ribose) polymerase (PARP) inhibitor used to treat ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer. | Poly (ADP-ribose) polymerase (PARP) inhibitors |
| Oleic Acid | 282.4614 C18H34O2 |  | A naturally occurring fatty acid with antibacterial properties added to a variety of drug products. | Oleic Acids |
| Oliceridine | 386.55 C22H30N2O2S |  | A biased opioid agonist indicated for the management of severe acute pain in adult patients. Through preferential activation of G-protein-coupled signalling pathways, oliceridine provides analgesic effect with a comparable or improved safety profile over conventional opioid agonists. | Ligands |
| Olmesartan | 446.5016 C24H26N6O3 |  | An angiotensin receptor blocker (ARB) used in the treatment of hypertension. | Angiotensin II Antagonists and Calcium Channel Blockers / Angiotensin II receptor blockers (ARBs) and calcium channel blockers / Angiotensin II receptor blockers (ARBs) and diuretics |
| Olodaterol | 386.448 C21H26N2O5 |  | A long-acting beta2-adrenergic agonist used in the management of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. | Agents producing tachycardia / Agents that produce hypertension |
| Olopatadine | 337.4122 C21H23NO3 |  | A histamine H1 antagonist used to treat allergic conjunctivitis and rhinitis. | Antiallergic Agents, Excl. Corticosteroids |
| Olsalazine | 302.239 C14H10N2O6 |  | An anti-inflammatory aminosalicylate used in the treatment of inflammatory bowel disease and ulcerative colitis. | Salicylates |
| Olutasidenib | 354.79 C18H15ClN4O2 |  | An isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for the treatment of patients with relapsed or refractory acute myeloid leukemia with a susceptible IDH1 mutation as detected by an FDA-approved test. | Antineoplastic Agents / BCRP/ABCG2 Inhibitors / Cytochrome P-450 CYP1A2 Inducers / Cytochrome P-450 CYP1A2 Inducers (strength unknown) / Cytochrome P-450 CYP1A2 Substrates / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C8 Inducers / Cytochrome P-450 CYP2C8 Inducers (strength unknown) / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP2C9 Inducers / Cytochrome P-450 CYP2C9 Inducers (strength unknown) / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Substrates / Enzyme Inhibitors / Heterocyclic Compounds, Fused-Ring / Isocitrate dehydrogenase-1 (IDH1) inhibitors / Isocitrate Dehydrogenase-1 Inhibitors / MATE 1 Inhibitors / MATE 2 Inhibitors / MATE inhibitors / OAT3/SLC22A8 Inhibitors / OATP1B1/SLCO1B1 Inhibitors / OATP1B3 inhibitors / OCT2 Inhibitors / P-glycoprotein inhibitors / Potential QTc-Prolonging Agents / QTc Prolonging Agents |
| Omacetaxine mepesuccinate | 545.6213 C29H39NO9 |  | A cephalotaxine used in the treatment of Chronic Myeloid Leukemia (CML) that is intolerant to or resistant to two or more tyrosine kinase inhibitors. | Antineoplastic Agents |
| Omadacycline | 556.66 C29H40N4O7 |  | A tetracycline antibiotic used to treat community acquired bacterial pneumonia. | Tetracyclines |
| Omaveloxolone | 554.723 C33H44F2N2O3 |  | A semisynthetic triterpenoid used to treat Friedreich’s ataxia in adults and adolescents 16 years and older. | Anti-Inflammatory Agents / Antioxidants / Cytochrome P-450 CYP2C8 Inducers / Cytochrome P-450 CYP2C8 Inducers (weak) / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (weak) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Substrates / OAT1/SLC22A6 inhibitors / Oxidation-Reduction Agent / Terpenes / Triterpenes |
| Ombitasvir | 894.127 C50H67N7O8 |  | A direct acting antiviral agent used in combination with other antiviral agents for the treatment of Hepatitis C Virus (HCV) infections. | Antivirals for treatment of HCV infections |
| Omega-3 fatty acids | Not Available |  | An ingredient found in a variety of supplements and vitamins. | Liver Therapy |
| Omega-3-acid ethyl esters | Not Available |  | A mixture of fatty acids used as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe hypertriglyceridemia. | Fatty Acids, Omega-3 / Nootropic Agents |
| Omega-3-carboxylic acids | Not Available |  | A medication used with other medications to lower triglyceride levels in adult patients with severe hypertriglyceridemia. | Fatty Acids, Omega-3 |
| Omeprazole | 345.416 C17H19N3O3S |  | A proton pump inhibitor used to treat GERD associated conditions such as heartburn and gastric acid hypersecretion, and to promote healing of tissue damage and ulcers caused by gastric acid and H. pylori infection. | 2-Pyridinylmethylsulfinylbenzimidazoles / Anti-Ulcer Agents / Proton Pump Inhibitors |
| Omidenepag isopropyl | 520.61 C26H28N6O4S |  | An agonist of the prostaglandin EP2 receptor indicated for the reduction of elevated intraocular pressure. | Antiglaucoma Agents / Hypotensive Agents / Ophthalmic Solutions / Ophthalmics / Prodrugs / Pyrazoles / Pyridines / Receptors, Prostaglandin E, EP2 Subtype, agonists / Sulfonamides |
| Ondansetron | 293.363 C18H19N3O |  | A serotonin 5-HT3 receptor antagonist used to prevent nausea and vomiting in cancer chemotherapy and postoperatively. | Anti-Anxiety Agents / Antiemetics / Carbazoles / Imidazoles / Serotonin 5-HT3 Receptor Antagonists / Serotonin Receptor Antagonists |
| Opicapone | 413.17 C15H10Cl2N4O6 |  | A catechol-O-methyltransferase inhibitor used as an adjunct treatment for Parkinson's Disease in adults currently receiving levodopa and a dopa decarboxylase inhibitor. | COMT Inhibitors |
| Opium | Not Available |  | A medication used to treat moderate to severe pain. | Natural Opium Alkaloids |
| Orciprenaline | 211.2576 C11H17NO3 |  | A beta-2 adrenergic agonist used to treat bronchospasm, asthma, and COPD. | Non-selective Beta-adrenergic Agonists |
| Oritavancin | 1793.101 C86H97Cl3N10O26 |  | An antibacterial agent used to treat acute bacterial skin and skin structure infections caused by susceptible Gram-positive bacteria. | Glycopeptide Antibacterials |
| Orlistat | 495.7348 C29H53NO5 |  | A reversible inhibitor of gastrointestinal lipases indicated for weight loss and weight maintenance. | Peripherally Acting Antiobesity Products |
| Ornithine | 132.161 C5H12N2O2 |  | An amino acid commonly found as a component in total parenteral nutrition. | Liver Therapy |
| Orphenadrine | 269.3813 C18H23NO |  | A muscarinic antagonist used as an adjunct for the symptomatic relief of musculoskeletal pain and discomfort. | Ethers, Chemically Close to Antihistamines |
Displaying drugs 1826 - 1850 of 2779 in total